Photo Cred: Andrea Crisanti By Katherine Shagoury Antibody levels remain high nine months after infection with SARS-CoV-2, the virus that causes the novel coronavirus (COVID-19), whether symptomatic or asymptomatic, according...
Read MorePhoto Cred: Mufid Majnun/Unsplash By Katherine Shagoury The U.S. Food and Drug Administration announced this week revisions to the vaccine recipient and vaccination provider fact sheets for the Johnson &...
Read MorePhoto Cred: Mohammad Shahhosseini/Unsplash By Katherine Shagoury The companies behind one of the three novel coronavirus (COVID-19) vaccinations authorized for emergency use, Pfizer and BioNTech, met with health officials on...
Read MorePhoto Cred: Brett Sayles/Pexels By Katherine Shagoury A survey offered to transgender and nonbinary people across six continents and in thirteen languages shows that during the first months of the...
Read MorePhoto Cred: Australian Red Cross Lifeblood By Katherine Shagoury In a new study published in the journal PLOS Medicine, researchers from the University of Sydney looked at how the immune...
Read MorePhoto Cred: Kelly Sikkema/Unsplash By Katherine Shagoury People with the novel coronavirus (COVID-19) may experience milder symptoms if certain cells of their immune systems “remember” previous encounters with seasonal coronaviruses,...
Read MorePhoto Cred: CDC/Pexels By Katherine Shagoury Two doses of the inactivated novel coronavirus (COVID-19) vaccine, CoronaVac, manufactured by Sinovac, are safe and provoke a strong antibody response among 550 children...
Read MorePhoto Cred: Martha Dominguez de Gouveia/Unsplash By Katherine Shagoury Novel coronavirus (COVID-19)-positive patients with traumatic injuries have six times higher risk of death and complication than patients without COVID-19, according...
Read More